Intel Holds Off on Leixlip Factory and 3 Dow Movers Sparking Chatter
Intel Corporation (NASDAQ:INTC): Current price $20.94
Intel is deferring its plans to construct a new factory that would result in the creation more than 4,000 jobs in Leixlip, says the Irish Independent. The firm has been given the greenlight by an Bord Pleanala for a 40-hectare expansion, but its corporate office in Silicon Valley has not yet okayed the development.
JPMorgan Chase & Co. (NYSE:JPM): Current price $46.97
Analyst Matt O’Connor at Deutsche Bank has upgraded JPMorgan to Buy from Hold and downgraded Goldman Sach Group (NYSE:GS) to Hold from Buy in a note to investors earlier Friday, saying that JPMorgan’s cost savings should surpass expectations by a wide margin, and it should benefit more than will its peers from consumer loan growth over the longer term. Further, JPMorgan’s shares have underperformed other large bank stocks since August 2012, said O’Connor, who raised his price target on the shares from $48 to $53.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Merck & Co. (NYSE:MRK): Current price $43.08
Merck’s Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older, has been cleared by the FDA. The medication will remain available for men with overactive bladder by prescription only.
International Business Machines Corporation (NYSE:IBM): Current price $204.89
IBM’s nanomedicine program, established only four years ago, has created a new antimicrobial gel designed to supplant antibiotics in combating certain drug-resistant infections, said The Financial Times, which noted that the gel is in early research stages and it is uncertain how well it might work in practical applications.
Don’t Miss: Can Dell Do Better Than Silver Lake?